Novartis today announced that the US Food and Drug Administration (FDA) has approved Itvisma® (onasemnogene abeparvovec-brve) for the treatment of children two years and older, teens, and adults ...

A research team has found that specific immune cells can connect with muscle fibers in a lightning-fast, neuron-like way to ...

For me, strength and fitness is now about having the power to lift my toddler and run around after her for years to come. So ...

In the context of "Pharmacology Made Easy 5.0," a test on the cardiovascular system would likely focus on the following key ...